ES2170918T3 - Inhibidor de proteina quinasa c sustituidos con halo. - Google Patents
Inhibidor de proteina quinasa c sustituidos con halo.Info
- Publication number
- ES2170918T3 ES2170918T3 ES97302996T ES97302996T ES2170918T3 ES 2170918 T3 ES2170918 T3 ES 2170918T3 ES 97302996 T ES97302996 T ES 97302996T ES 97302996 T ES97302996 T ES 97302996T ES 2170918 T3 ES2170918 T3 ES 2170918T3
- Authority
- ES
- Spain
- Prior art keywords
- halo
- quinase
- protein
- inhibitor
- replaced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A NUEVOS COMPUESTOS DE BIS INDOLMALEIMIDA HALO ON TAMBIEN SE REFIERE A UN METODO PARA LA PREPARACION DE LOS COMPUESTOS PRESENTADOS Y PARA LA PREPARACION DE UNA FORMULACION FARMACEUTICA A UTILIZAR EN LA INHIBICION DE LA CINASA C DE PROTEINAS EN MAMIFEROS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1638296P | 1996-05-01 | 1996-05-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2170918T3 true ES2170918T3 (es) | 2002-08-16 |
Family
ID=21776838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97302996T Expired - Lifetime ES2170918T3 (es) | 1996-05-01 | 1997-05-01 | Inhibidor de proteina quinasa c sustituidos con halo. |
Country Status (21)
Country | Link |
---|---|
US (1) | US5936084A (es) |
EP (1) | EP0805158B1 (es) |
JP (1) | JP3235840B2 (es) |
KR (1) | KR20000065137A (es) |
AT (1) | ATE212026T1 (es) |
AU (1) | AU703395B2 (es) |
BR (1) | BR9709301A (es) |
CA (1) | CA2252701C (es) |
CZ (1) | CZ347098A3 (es) |
DE (1) | DE69709568T2 (es) |
DK (1) | DK0805158T3 (es) |
EA (1) | EA001450B1 (es) |
ES (1) | ES2170918T3 (es) |
IL (1) | IL126762A0 (es) |
NO (1) | NO310416B1 (es) |
NZ (1) | NZ332658A (es) |
PL (1) | PL329681A1 (es) |
PT (1) | PT805158E (es) |
TR (1) | TR199802193T2 (es) |
WO (1) | WO1997041127A1 (es) |
YU (1) | YU48398A (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6127401A (en) * | 1998-06-05 | 2000-10-03 | Cephalon, Inc. | Bridged indenopyrrolocarbazoles |
US7425537B2 (en) * | 2000-08-22 | 2008-09-16 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | SH2 domain binding inhibitors |
MXPA03005139A (es) * | 2000-12-08 | 2004-01-29 | Ortho Mcneil Pharm Inc | Compuestos macroheterociclicos utiles como inhibidores de cinasa. |
EP1441772A2 (en) * | 2001-10-29 | 2004-08-04 | Nektar Therapeutics Al, Corporation | Polymer conjugates of protein kinase c inhibitors |
ES2355472T3 (es) * | 2002-05-22 | 2011-03-28 | Amgen Inc. | Derivados de aminopirimidina para su uso como ligandos del receptor vaniloide para el tratamiento del dolor. |
US7144888B2 (en) | 2002-08-08 | 2006-12-05 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
DE10244453A1 (de) * | 2002-09-24 | 2004-04-01 | Phenomiques Gmbh | Hemmung der Proteinkinase C-alpha zur Behandlung von Krankheiten |
US7245117B1 (en) * | 2004-11-01 | 2007-07-17 | Cardiomems, Inc. | Communicating with implanted wireless sensor |
CA2556239A1 (en) | 2004-02-11 | 2005-08-25 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
MY139645A (en) | 2004-02-11 | 2009-10-30 | Amgen Inc | Vanilloid receptor ligands and their use in treatments |
CN101023094B (zh) | 2004-07-21 | 2011-05-18 | 法莫赛特股份有限公司 | 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备 |
ES2769377T3 (es) | 2004-09-14 | 2020-06-25 | Gilead Pharmasset Llc | Intermedios de D-ribonolactona con sustitución de 2-fluoro-2-alquilo |
WO2006089311A1 (en) * | 2005-02-15 | 2006-08-24 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
EP1877424A4 (en) * | 2005-04-11 | 2010-09-29 | Pharmagap Inc | INHIBITORS OF PROTEIN KINASES AND USES THEREOF |
WO2006113769A1 (en) * | 2005-04-15 | 2006-10-26 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
WO2010049947A2 (en) * | 2008-10-28 | 2010-05-06 | Accrete Pharmaceutical Private Limited | Preparation of gemcitabine and intermediates thereof |
US9126931B2 (en) * | 2009-06-10 | 2015-09-08 | Chugai Seiyaku Kabushiki Kaisha | Tetracyclic compound |
WO2012023597A1 (ja) | 2010-08-20 | 2012-02-23 | 中外製薬株式会社 | 4環性化合物を含む組成物 |
TR201815994T4 (tr) | 2012-09-25 | 2018-11-21 | Chugai Pharmaceutical Co Ltd | Ret inhibitörü. |
CA2946268A1 (en) | 2014-04-25 | 2015-10-29 | Chugai Seiyaku Kabushiki Kaisha | Crystal of tetracyclic compound |
KR102412321B1 (ko) | 2014-04-25 | 2022-06-22 | 추가이 세이야쿠 가부시키가이샤 | 4환성 화합물을 고용량 함유하는 제제 |
TWI718102B (zh) | 2014-08-08 | 2021-02-11 | 日商中外製藥股份有限公司 | 4環性化合物的非晶質體 |
RU2740261C2 (ru) | 2015-01-16 | 2021-01-12 | Чугаи Сейяку Кабусики Кайся | Комбинированное лекарственное средство |
WO2019000224A1 (zh) * | 2017-06-27 | 2019-01-03 | 中国海洋大学 | 双吲哚马来酰亚胺衍生物及其制备方法和用途 |
WO2020050241A1 (ja) | 2018-09-04 | 2020-03-12 | 中外製薬株式会社 | 4環性化合物の製造方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5438050A (en) * | 1988-02-06 | 1995-08-01 | Godecke Aktiengesellschaft | Indolocarbazole derivatives, processes for their preparation and compositions containing them |
US5380746A (en) * | 1989-05-05 | 1995-01-10 | Goedecke Aktiengesellschaft | Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
US5589472A (en) * | 1992-09-25 | 1996-12-31 | Vice; Susan F. | Diindolo compounds and pharmaceutical compositions containing them |
UA44690C2 (uk) * | 1993-12-07 | 2002-03-15 | Елі Ліллі Енд Компані | Макроциклічна сполука іміду біс-індол-малеїнової кислоти, спосіб її одержання та фармацевтична композиція, макроциклічні сполуки іміду біс-індол-малеїнової кислоти та біс-індол-малеїнового ангідриду, спосіб одержання (варіанти) |
US5624949A (en) * | 1993-12-07 | 1997-04-29 | Eli Lilly And Company | Protein kinase C inhibitors |
US5472183A (en) * | 1994-03-17 | 1995-12-05 | Nisca Corporation | Sheet feeding device with multiple sheet stackers |
US5559228A (en) * | 1995-03-30 | 1996-09-24 | Eli Lilly And Company | Synthesis of bisindolylmaleimides |
US5696949A (en) * | 1995-06-15 | 1997-12-09 | Intel Corporation | System for PCI slots expansion using asynchronous PCI-to-PCI bridge with clock generator for providing clock signal to the expansion mother board and expansion side of bridge |
-
1997
- 1997-04-30 BR BR9709301A patent/BR9709301A/pt unknown
- 1997-04-30 US US08/846,272 patent/US5936084A/en not_active Expired - Fee Related
- 1997-04-30 IL IL12676297A patent/IL126762A0/xx unknown
- 1997-04-30 YU YU48398A patent/YU48398A/sh unknown
- 1997-04-30 CA CA002252701A patent/CA2252701C/en not_active Expired - Fee Related
- 1997-04-30 TR TR1998/02193T patent/TR199802193T2/xx unknown
- 1997-04-30 AU AU29292/97A patent/AU703395B2/en not_active Ceased
- 1997-04-30 CZ CZ983470A patent/CZ347098A3/cs unknown
- 1997-04-30 NZ NZ332658A patent/NZ332658A/xx unknown
- 1997-04-30 KR KR1019980708737A patent/KR20000065137A/ko active IP Right Grant
- 1997-04-30 WO PCT/US1997/007302 patent/WO1997041127A1/en not_active Application Discontinuation
- 1997-04-30 EA EA199800966A patent/EA001450B1/ru not_active IP Right Cessation
- 1997-04-30 PL PL97329681A patent/PL329681A1/xx unknown
- 1997-04-30 JP JP52234397A patent/JP3235840B2/ja not_active Expired - Fee Related
- 1997-05-01 PT PT97302996T patent/PT805158E/pt unknown
- 1997-05-01 EP EP97302996A patent/EP0805158B1/en not_active Expired - Lifetime
- 1997-05-01 DE DE69709568T patent/DE69709568T2/de not_active Expired - Fee Related
- 1997-05-01 DK DK97302996T patent/DK0805158T3/da active
- 1997-05-01 AT AT97302996T patent/ATE212026T1/de not_active IP Right Cessation
- 1997-05-01 ES ES97302996T patent/ES2170918T3/es not_active Expired - Lifetime
-
1998
- 1998-10-30 NO NO19985080A patent/NO310416B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2252701C (en) | 2003-10-28 |
EA199800966A1 (ru) | 1999-04-29 |
AU2929297A (en) | 1997-11-19 |
KR20000065137A (ko) | 2000-11-06 |
CA2252701A1 (en) | 1997-11-06 |
DE69709568D1 (de) | 2002-02-21 |
EP0805158A3 (en) | 1998-04-01 |
US5936084A (en) | 1999-08-10 |
BR9709301A (pt) | 1999-08-10 |
NO985080L (no) | 1998-12-08 |
JPH11509233A (ja) | 1999-08-17 |
NZ332658A (en) | 2000-05-26 |
JP3235840B2 (ja) | 2001-12-04 |
PL329681A1 (en) | 1999-04-12 |
IL126762A0 (en) | 1999-08-17 |
PT805158E (pt) | 2002-06-28 |
CZ347098A3 (cs) | 1999-06-16 |
DK0805158T3 (da) | 2002-03-18 |
WO1997041127A1 (en) | 1997-11-06 |
DE69709568T2 (de) | 2002-09-05 |
TR199802193T2 (xx) | 1999-02-22 |
EP0805158B1 (en) | 2002-01-16 |
NO985080D0 (no) | 1998-10-30 |
EA001450B1 (ru) | 2001-04-23 |
YU48398A (sh) | 2000-12-28 |
EP0805158A2 (en) | 1997-11-05 |
ATE212026T1 (de) | 2002-02-15 |
AU703395B2 (en) | 1999-03-25 |
NO310416B1 (no) | 2001-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2170918T3 (es) | Inhibidor de proteina quinasa c sustituidos con halo. | |
ES2162843T3 (es) | Inhibidores de la proteina quinasa c. | |
YU25497A (sh) | Postupak za dobijanje sildenafila | |
TW371661B (en) | Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides | |
ATE135352T1 (de) | 3-keto-hmg-coa reduktase-inhibitoren | |
GB9617822D0 (en) | Pharmaceutical compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 805158 Country of ref document: ES |